114.05
price down icon0.24%   -0.27
pre-market  Pre-market:  117.49   3.44   +3.02%
loading

Why is Blueprint Medicines Corp (BPMC) Stock down?

02 Aug, 2023:

Shares of Blueprint Medicines (BPMC) were down more than 15.34% to $54.30 on Wednesday after the healthcare company announced second-quarter earnings. While the numbers were generally positive, investors are likely to sell on good news, taking advantage of a positive announcement, but the selling got out of hand.

https://www.fool.com/investing/2023/08/02/why-shares-of-blueprint-medicines-are-falling-wedn/

$352.30
price down icon 5.49%
$41.04
price up icon 0.79%
$22.36
price up icon 3.33%
$5.41
price up icon 3.84%
biotechnology ONC
$226.89
price up icon 0.08%
$120.88
price down icon 0.23%
Cap:     |  Volume (24h):